top of page

AmebaGone is advancing the fight against intractable bacterial infections

Our technology harnesses the natural predatory behavior of Dicty amoebae to kill bacteria.

 

Our goal is to end the overuse of antibiotics and provide a safer way to control pathogenic microbes.

Our technology

For millennia, bacteria have had a natural predator: the amoebae.

 

Much like lions or wolves, Dicty amoebae are group hunters, and they excel at finding and consuming their natural prey: bacteria, which in some cases can threaten human life.

 

Unlike lions, they don’t hunt a single bacterial specimen: amoebae can consume an entire biofilm containing billions of cells.

pexels-thisisengineering-3862603.jpg
pexels-jess-loiterton-9259942.jpg

Our innovation

Antimicrobial resistance is a serious problem for modern medicine.

 

The bacteria involved in chronic intractable infections routinely feature antimicrobial resistant biofilms. Conventional antibiotics can’t do anything about that.

 

But our technology can. 

For more information about the severity of antimicrobial resistance (AMR) visit the WHO's webpage.

Our team

With a deep bench of research specialization in amoebic biocontrol and partnerships across the scientific, agricultural, and medical fields, AmebaGone is developing disruptive technology that challenges the conventional use of chemical antibiotics.

pexels-alex-green-5691866.jpg

Latest News

BPC-Logo-2COLOR-2019-435x200.png

AmebaGone advances to Phase 2 of the Wisconsin Governor's Business Plan Contest. 

Read more

AmebaGone awarded NIH Phase II SBIR grant to further Bacterial Keratitis treatment research. 

Read more

NIH.jpg

Amebagone Inc. Selected to Present at the 2017 Ag Innovation Showcase (Sept 11-13) in St. Louis, MO. 

Read more

Ag Innovation Showcase.jpg

Never miss an update! Subscribe to our mailing list.

Subscribe

Funding and support

Cleantech Open.png
lartra.png
USDA_logo.png
National Science Foundation.jpg
NIH.jpg
NIFA.png
Wisconsin-Economic-Development-Corporati
SBIR_STTR_hires.png
MDC.png
WARF.png

Funds raised to date

$3.4 million

Awards and prizes

3rd Place:

BPC-Logo-2COLOR-2019-435x200.png

Semifinalist:

( 2017 )

BIG-CLEANTECHmidwest-300x213.png

Patents

AmebaGone and AgraFilms (our sister company) hold broad US and EU patents protecting multiple uses of Dicty in medicine, agriculture and industry.

 

We are the only two firms globally that have developed Dicty-derived products as antimicrobial agents. 

 

Read more

bottom of page